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The posteradication phase (high containment) begins 1 year
after identification of the world’s last case. At that time,
laboratories holding wild poliovirus stocks and potentially
infectious materials must either place all materials under
appropriate biosafety conditions, transfer important virus
isolates to WHO interim repositories, or render all wild
poliovirus materials noninfectious. Documentation of con-
tainment compliance by all regions is required for global
certification of poliovirus eradication. For countries that
intend to stop all poliovirus vaccination, work with materials
that could cause infection with wild poliovirus must be
conducted under BSL 4 containment. High containment (BSL 3/
polio) will be required for work with vaccine-derived viruses.
High-level political involvement and multi-sector commit-
ments, including departments of health, defense, education,
environment, and private industry are essential to achieving
and maintaining global containment of wild poliovirus.
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Over 300 infectious diseases occur and are challenged by
over 250 drugs and vaccines. Fifteen hundred species of
pathogenic bacteria, viruses, parasites, and fungi have been
described, and printed media can no longer keep up with the
dynamics of diseases, outbreaks, and epidemics in “real time.”
Although electronic media have given us unlimited
information access, the search for meaningful data is
confusing and time-consuming. Global Infectious Diseases
and Epidemiology Network (GIDEON) is a computer software
program that was developed for disease simulation and
informatics in the fields of geographic and travel medicine.
GIDEON is currently used in 1,500 sites in 45 countries:
health ministries, military installations, travel clinics,
libraries and student teaching modules, clinical departments,
laboratories, and missionary agencies. The program consists
of four components. The first generates a Bayesian ranked
differential diagnosis based on signs, symptoms, laboratory
tests, country of origin, and incubation period and can be used
for diagnostic support and simulation of all infectious
diseases in all countries. In a blind trial conducted on 495
patients, the correct diagnosis was included in the differential
diagnosis list in 94.7% of cases (sensitivity) and displayed as
the first disease in the list in 75% (specificity).
The second component presents the epidemiology of
individual diseases, including their global effects and status
in each of 205 countries and regions. All past and current
outbreaks are described in detail, and a web-based version
under development will allow for daily updating online. The
user may also access a list of diseases related to any agent,
vector, vehicle, reservoir or country or any combination of all
five (i.e., a list of all mosquito-borne viruses of Brazil which
have an avian reservoir).
The third module is an interactive encyclopedia which
includes information on the pharmacology, use, testing
standards, and global trade names of all antiinfective drugs
and vaccines.
The fourth module is designed to identify all species of
bacteria, mycobacteria, and yeasts. The database includes 50
to 100 additional taxa that may not appear in standard texts
and laboratory databases for several months. Other options
allow the user to add data relevant to his own institution,
electronic patient charts, material from the Internet,
important telephone numbers, drug prices, antimicrobial
resistance patterns, and other information. This form of
custom data input is particularly useful when running
GIDEON on institutional networks because software
administrators can use it to disseminate and file information
relevant to their own institution for use by all computers on
their network. The data in GIDEON are derived from all peer-
reviewed journals in the fields of infectious diseases,
pediatrics, internal medicine, tropical medicine, travel
medicine, antimicrobial pharmacology, and clinical microbi-
ology; a monthly electronic literature search based on all
relevant terms in GIDEON (e.g., diseases, drugs, etc.) all
available health ministry reports (both printed and
electronic); standard texts; and abstracts of major meetings.
Further details regarding the program are available at
http://www.cyinfo.com.
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